Alice Bernard-Tessier

11PUBLICATIONS
167CO-AUTHORS
Predictive and prognostic markersChemotherapyMolecular targetsNeurology and neuromuscular diseasesPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 23, 2026
Gustave Roussy Immune (GRIm) score validation in patients treated with Bispecific CD3 T-cell engagers in phase I clinical trials.

|Aug 31, 2026
Vitronectin Enrichment in Prostate Cancer Liver Metastases Promotes Adhesion and Survival.

|Jun 02, 2026
Phase Ib Trial of Bavdegalutamide (ARV-110) in Combination with Abiraterone for Metastatic Prostate Cancer.

|Oct 02, 2025
The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyond.

Alice Bernard-Tessier, Natacha Naoun, Solenn Barraud

|Aug 07, 2025
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.

Mihaela Aldea, Emeline Orillard, Alice Bernard-Tessier

|Jul 21, 2025
Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study.

Rahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier

Pageof 2

Frequent Collaborators

3 joint publications

Karim Fizazi

2 joint publications

Yohann Loriot

2 joint publications

Xin Gao

2 joint publications

Sylvie Rottey